by Madaline Spencer | Apr 10, 2026
Systemic mastocytosis is a rare disease in which excess mast cells are produced and activated, resulting in chronic, severe, and heterogenous symptoms. CheckRare spoke with Patrick C. Foy, MD, a Clinical Hematologist practicing at Froedtert Hospital, Milwaukee, and...
by Madaline Spencer and Joe Haddad | Apr 9, 2026
The US Food and Drug Administration (FDA) has approved Tecartus (brexucabtagene autoleucel) for the treatment of adults with relapsed or refractory (R/R) mantle cell lymphoma (MCL). MCL is a rare form of malignant non-Hodgkin lymphoma affecting B lymphocytes in the...
by Madaline Spencer | Apr 7, 2026
Miquel Vila-Perello, PhD, co-founder and CEO of SpliceBio, discusses an investigational dual adeno-associated virus (AAV) gene therapy in development for patients with Stargardt disease. Stargardt disease is a genetic eye disorder characterized by...
by Madaline Spencer | Apr 6, 2026
Richard A. Furie, MD, Chief of the Division of Rheumatology at Northwell Health, discusses nipocalimab for the treatment of systemic lupus erythematosus (SLE). SLE is an autoimmune disease characterized by inflammation in the connective tissues, leading to...
by Madaline Spencer | Apr 3, 2026
A study published in World Journal of Clinical Cases investigated the psychological aspects of rare autoimmune and ophthalmic diseases, such as mental well-being and everyday functioning. The goal of this study was to analyze descriptive case series reporting in 18...
